Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion 15 Jul Written By Alexandra Collingbourne Alexandra Collingbourne
Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion 15 Jul Written By Alexandra Collingbourne Alexandra Collingbourne
